# Can an AI agent speed up pharma promotional review (MLR)?

> Moderna is an early-access user of Veeva AI's Quick Check Agent in PromoMats, which scans promotional content against editorial, brand, market, channel, and compliance guidelines before medical-legal-regulatory (MLR) review. Moderna says it moves the company closer to parts of MLR becoming 'nearly touch-free'; no metrics were published.

- **Evidence grade:** C — Named organization, no specific outcome (deployment announced only, or only vague qualitative claims).
- **Organization:** Moderna (biotech company)
- **Industry:** Pharma, Biotech & Life Sciences — Biotech / vaccines
- **Roles:** Marketing Ops & MLR
- **Tools:** Quick Check Agent (PromoMats) (Veeva Systems)
- **Status:** pilot · **Agent pattern:** workflow-agent · **Autonomy:** 1/4
- **Last verified:** 2026-10-17

## Reported outcomes
- None quantified in sources.

## How it works
1. Marketer submits a draft piece into PromoMats.
2. Quick Check Agent scans it against editorial, brand, market, channel, and compliance guidelines.
3. Issues are surfaced before the piece enters formal MLR review.

## Risks & compliance
- Final MLR approval remains human
- Off-label or unsubstantiated claims must still be caught by reviewers

## MedTech angle
Device marketing teams run the same promotional-review gauntlet; pre-review checks are a low-risk first agent.

## Sources
1. Veeva Systems, "Veeva AI Agents Now Available to Increase Productivity and Customer Centricity" (2025-12-03) <https://www.veeva.com/resources/veeva-ai-agents-now-available-to-increase-productivity-and-customer-centricity/>
   > "What we’ve learned as an early access user is that the Veeva AI Quick Check Agent moves Moderna closer to a process where parts of MLR could become nearly touch-free."

Canonical: https://agentcasefile.com/cases/moderna-veeva-quick-check-agent-mlr/ · License: CC BY 4.0 (summary) · Source: Agent Casefile